Compare BIPC & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIPC | ITGR |
|---|---|---|
| Founded | 2019 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.3B |
| IPO Year | 2019 | 2000 |
| Metric | BIPC | ITGR |
|---|---|---|
| Price | $36.29 | $126.39 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $45.00 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 919.9K | 663.7K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.17 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $7.85 | $1.69 |
| Revenue Next Year | $5.94 | $6.53 |
| P/E Ratio | ★ N/A | $108.01 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $34.18 | $62.00 |
| 52 Week High | $51.72 | $126.80 |
| Indicator | BIPC | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 35.14 | 75.87 |
| Support Level | $34.18 | $124.84 |
| Resistance Level | $42.84 | $126.80 |
| Average True Range (ATR) | 0.94 | 0.28 |
| MACD | -0.20 | -0.74 |
| Stochastic Oscillator | 16.34 | 61.34 |
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.